Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review.
Barone B, Calogero A, Scafuri L, Ferro M, Lucarelli G, Di Zazzo E, Sicignano E, Falcone A, Romano L, De Luca L, Oliva F, Mirto BF, Capone F, Imbimbo C, Crocetto F. Barone B, et al. Among authors: ferro m. Cancers (Basel). 2022 May 21;14(10):2545. doi: 10.3390/cancers14102545. Cancers (Basel). 2022. PMID: 35626149 Free PMC article. Review.
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
Di Lorenzo G, Cartenì G, Autorino R, Gonnella A, Perdonà S, Ferro M, Longo N, Rescigno P, Doria F, Faiella A, Altieri V, Palmieri G, Imbimbo C, Mirone V, De Placido S. Di Lorenzo G, et al. Among authors: ferro m. Anticancer Drugs. 2009 Apr;20(4):277-80. doi: 10.1097/CAD.0b013e328329a293. Anticancer Drugs. 2009. PMID: 19262371 Clinical Trial.
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging.
de Cobelli O, Terracciano D, Tagliabue E, Raimondi S, Bottero D, Cioffi A, Jereczek-Fossa B, Petralia G, Cordima G, Almeida GL, Lucarelli G, Buonerba C, Matei DV, Renne G, Di Lorenzo G, Ferro M. de Cobelli O, et al. Among authors: ferro m. PLoS One. 2015 Oct 7;10(10):e0139696. doi: 10.1371/journal.pone.0139696. eCollection 2015. PLoS One. 2015. PMID: 26444548 Free PMC article.
Biomarkers in localized prostate cancer.
Ferro M, Buonerba C, Terracciano D, Lucarelli G, Cosimato V, Bottero D, Deliu VM, Ditonno P, Perdonà S, Autorino R, Coman I, De Placido S, Di Lorenzo G, De Cobelli O. Ferro M, et al. Future Oncol. 2016 Feb;12(3):399-411. doi: 10.2217/fon.15.318. Epub 2016 Jan 15. Future Oncol. 2016. PMID: 26768791 Free PMC article. Review.
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review.
Di Lorenzo G, De Placido S, Pagliuca M, Ferro M, Lucarelli G, Rossetti S, Bosso D, Puglia L, Pignataro P, Ascione I, De Cobelli O, Caraglia M, Aieta M, Terracciano D, Facchini G, Buonerba C, Sonpavde G. Di Lorenzo G, et al. Among authors: ferro m. Expert Opin Biol Ther. 2016 Nov;16(11):1387-1401. doi: 10.1080/14712598.2016.1216964. Epub 2016 Aug 5. Expert Opin Biol Ther. 2016. PMID: 27463642
The emerging role of obesity, diet and lipid metabolism in prostate cancer.
Ferro M, Terracciano D, Buonerba C, Lucarelli G, Bottero D, Perdonà S, Autorino R, Serino A, Cantiello F, Damiano R, Andras I, De Placido S, Di Lorenzo G, Battaglia M, Jereczek-Fossa BA, Mirone V, De Cobelli O. Ferro M, et al. Future Oncol. 2017 Feb;13(3):285-293. doi: 10.2217/fon-2016-0217. Epub 2016 Sep 14. Future Oncol. 2017. PMID: 27624840 Free PMC article. Review.
1,229 results